Defects in insulin action in chronic heart failure

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1463-1326.2000.00058.xPMID 11225653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Drugs on Glucose Tolerance in Non-Insulin-Dependent Diabetics (Part I)

  2012cited by this paper
• Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective beta-receptor blocking agent metoprolol.

  2009cited by this paper
• Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.

  2009cited by this paper
• Insulin resistance in chronic heart failure.

  2000cited by this paper
• THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE

  2000cited by this paper
• Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

  1999cited by this paper
• Epidemiology of insulin resistance and its relation to coronary artery disease.

  1999cited by this paper
• Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.

  1999cited by this paper
• Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.

  1999cited by this paper
• A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure.

  1999cited by this paper
• Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

  1999cited by this paper
• Insulin-mediated vasodilation and glucose uptake are functionally linked in humans.

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Loss of bone mineral in patients with cachexia due to chronic heart failure.

  1999cited by this paper
• Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension

  1999cited by this paper
• Heart failure: a medical hydra

  1998cited by this paper
• Endothelial function and dysfunction in heart failure.

  1998cited by this paper
• Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure.

  1998cited by this paper
• Captopril does not improve insulin action in essential hypertension: A double‐blind placebo‐controlled study

  1998cited by this paper
• Neurohormonal Activation in the Treatment of Congestive Heart Failure: Basis for New Treatments?

  1998cited by this paper
• Insulin resistance in hypertension is associated with body fat rather than blood pressure.

  1998cited by this paper
• An ideal worth fighting for.

  1998cited by this paper
• The epidemiology of heart failure.

  1997cited by this paper
• Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex.

  1997cited by this paper
• Skeletal muscle alterations in patients with chronic heart failure.

  1997cited by this paper
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease

  1997cited by this paper
• Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

  1997cited by this paper
• Adrenergic nervous system in heart failure.

  1997cited by this paper
• Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.

  1997cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.

  1997cited by this paper
• The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.

  1997cited by this paper
• The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.

  1997cited by this paper
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.

  1997cited by this paper
• Wasting as independent risk factor for mortality in chronic heart failure.

  1997cited by this paper
• Effect of Captopril, Losartan, and Bradykinin on Early Steps of Insulin Action

  1997cited by this paper
• Skeletal muscle function and its relation to exercise tolerance in chronic heart failure.

  1997cited by this paper
• Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure.

  1997cited by this paper
• Impaired Glucose Tolerance in Pima Indians

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

  1996cited by this paper
• Metabolic manifestations of low-dose diuretics.

  1996cited by this paper
• Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

  1996cited by this paper
• Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

  1996cited by this paper
• Physical training improves endothelial function in patients with chronic heart failure.

  1996cited by this paper
• The role of neurohormonal activation in chronic heart failure and postmyocardial infarction.

  1996cited by this paper
• Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

  1996cited by this paper
• Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training.

  1996cited by this paper
• Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.

  1996cited by this paper
• Insulin Action and Age: European Group for the Study of Insulin Resistance (EGIR)

  1996cited by this paper
• Oxidative stress and insulin action: is there a relationship?

  1996cited by this paper
• Lisinopril administration improves insulin action in aged patients with hypertension.

  1995cited by this paper
• Four week administration of an ACE inhibitor and a cardioselective β‐blocker in healthy volunteers: no influence on insulin sensitivity

  1995cited by this paper
• Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

  1995cited by this paper
• Predictors of exercise capacity in chronic heart failure.

  1994cited by this paper
• Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

  1994cited by this paper
• Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

  1994cited by this paper
• Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure.

  1994cited by this paper
• Insulin resistance in chronic heart failure.

  1994cited by this paper
• Changing epidemiological features of cardiac failure.

  1994cited by this paper
• Symptoms and quality of life in heart failure: the muscle hypothesis.

  1994cited by this paper
• Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link

  1994cited by this paper
• Long-term metabolic effects of antihypertensive drugs.

  1994cited by this paper
• Expanding the paradigm of the renin-angiotensin system and angiotensin-converting enzyme inhibitors.

  1994cited by this paper
• Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure.

  1994cited by this paper
• Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

  1994cited by this paper
• Heart Disease, Cancer, and Stroke Mortalit Trends And Their Interrelations: An International Perspective

  1994cited by this paper
• Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II

  1993cited by this paper
• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

  1993cited by this paper
• Insulin differentially regulates systemic and skeletal muscle vascular resistance.

  1993cited by this paper
• Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects

  1993cited by this paper
• On insulin action in vivo: the single gateway hypothesis.

  1993cited by this paper
• Insulin-mediated vasodilation: impairment with increased blood pressure and body mass.

  1993cited by this paper
• Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans.

  1993cited by this paper
• Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure

  1992cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results.

  1992cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

  1992cited by this paper
• The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

  1992cited by this paper
• Influence of Diuretics, Calcium Antagonists, and α‐Blockers on Insulin Sensitivity and Glucose Tolerance in Hypertensive Patients

  1992cited by this paper
• Hypertension and the microcirculation: a brief overview of experimental studies

  1992cited by this paper
• Endothelial function in chronic congestive heart failure.

  1992cited by this paper
• Angiotensin‐Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

  1992cited by this paper
• Insulin resistance--mechanisms, syndromes, and implications.

  1991cited by this paper
• Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

  1991cited by this paper
• Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

  1991cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  1990cited by this paper
• Insulin and atheroma. 20-yr perspective.

  1990cited by this paper
• Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

  1990cited by this paper
• Metabolic effects of controlled‐release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol

  1990cited by this paper
• Long term propranolol treatment and changes in body weight after myocardial infarction.

  1990cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.

  1990cited by this paper
• A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.

  1990cited by this paper
• Insulin resistance: a scientific and clinical challenge.

  1989cited by this paper
• Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

  1989cited by this paper
• Insulin transport across capillaries is rate limiting for insulin action in dogs.

  1989cited by this paper

• Der Einfluss von Angiotensinrezeptor Blockade mit Irbesartan auf die Insulinsensitivität bei Patienten mit systolischer Herzinsuffizienz - Ergebnisse einer randomisierten, Placebo kontrollierten

  2015cites this paper
• Ambulatory blood pressure monitoring and cardiac hypertrophy in children with metabolic syndrome

  2012cites this paper
• Insulin resistance and progression of heart failure in the older adult

  2011cites this paper
• Food and Western Disease Health and Nutrition from an Evolutionary Perspective

  2009cites this paper
• Cardiovascular risks associated with obesity in children and adolescents.

  2009cites this paper
• Cardiovascular risks associated with obesity in children and adolescents.

  2009cites this paper
• Pre-transplant obesity in heart transplantation: Are there predictors of worse outcomes?

  2009cites this paper
• Impaired glucose tolerance worsens exercise capacity and ventilatory response to exercise in patients with chronic heart failure.

  2007cites this paper
• The effect of testosterone on insulin sensitivity in men with heart failure

  2007cites this paper
• Obesity and the heart a weighty issue.

  2006cites this paper
• besity and the Heart Weighty Issue *

  2006cites this paper
• Left ventricular diastolic function in patients with impaired glucose tolerance and heart failure with low left ventricular ejection fraction

  2006cites this paper
• Czynność rozkurczowa lewej komory a nieprawidłowa tolerancja glukozy u chorych z niewydolnością serca i niską frakcją wyrzutową lewej komory

  2006cites this paper
• A Weighty Issue

  2006cites this paper
• Cardiovascular implications of thiazolidinedione therapy.

  2004cites this paper
• Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations.

  2004cites this paper
• The patient with diabetes mellitus and heart failure: at-risk issues.

  2003cites this paper
• Diabetes mellitus and heart failure.

  2003cites this paper